Published

Developing Core Consensus Measures for Assessment of Psilocybin Services

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Drug and Alcohol Dependence
Date: 2024-06-30
Source: OpenAlex
DOI: 10.1016/j.drugalcdep.2023.110268
PubMed: Unavailable

Authors

P. Todd Korthuis Kim Hoffman Adrianne R. Wilson-Poe Jason B. Luoma Alissa Bazinet David Morgan Sarann Bielavitz Dennis McCarty Christopher S. Stauffer

Watch author

Topics and keywords

psilocybin General Other Psilocybin Core (optical fiber)Hallucinogen Psychology Psychiatry Computer science Telecommunications Psychedelics and Drug Studies

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Developing Core Consensus Measures for Assessment of Psilocybin Services2024-06-30

Related papers

Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25 Psilocybin Outside the ClinicJAMA Psychiatry · 2025-11-04 Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22 Psilocybin has a narrow therapeutic window as an antidepressant treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-31 Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02